Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential. | Cancer Cell Int | 2022 | 36376832 | PubTator, text mining | PubMed |
| Long non-coding RNAs as novel prognostic biomarkers for breast cancer in Egyptian women. | Sci Rep | 2022 | 36376369 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing highlights the functional role of human endogenous retroviruses in gallbladder cancer. | EBioMedicine | 2022 | 36374772 | PubTator, text mining | PubMed |
| Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma. | BMC Gastroenterol | 2022 | 36371178 | PubTator, text mining | PubMed |
| The employment of vaccinia virus for colorectal cancer treatment: A review of preclinical and clinical studies. | Hum Vaccin Immunother | 2022 | 36369829 | PubTator, text mining | PubMed |
| Diagnostic and Therapeutic Implications of Long Non-Coding RNAs in Leukemia. | Life (Basel) | 2022 | 36362925 | PubTator, text mining | PubMed |
| Regulation of the Key Epithelial Cancer Suppressor miR-124 Function by Competing Endogenous RNAs. | Int J Mol Sci | 2022 | 36362406 | PubTator, text mining | PubMed |
| Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs. | Int J Mol Sci | 2022 | 36362222 | PubTator, text mining | PubMed |
| Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAs. | Int J Mol Sci | 2022 | 36361996 | PubTator, text mining | PubMed |
| MSF-UBRW: An Improved Unbalanced Bi-Random Walk Method to Infer Human lncRNA-Disease Associations. | Genes (Basel) | 2022 | 36360269 | PubTator, text mining | PubMed |
| Influence of Long Non-Coding RNA in the Regulation of Cancer Stem Cell Signaling Pathways. | Cells | 2022 | 36359888 | PubTator, text mining | PubMed |
| Breast Cancer Cells Reprogram the Oncogenic lncRNAs/mRNAs Coexpression Networks in Three-Dimensional Microenvironment. | Cells | 2022 | 36359853 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted Therapies. | Cancers (Basel) | 2022 | 36358625 | PubTator, text mining | PubMed |
| Constructing a novel competing Endogenous RNAs network based on NR3C1 and X-linked inhibitor of apoptosis protein genes reveals potential prognostic biomarkers in colorectal cancer. | J Res Med Sci | 2022 | 36353350 | PubTator, text mining | PubMed |
Expression of Concern: Downregulated lncRNA UCA1 acts as ceRNA to adsorb microRNA-498 to repress proliferation, invasion and epithelial mesenchymal transition of esophageal cancer cells by decreasing ZEB2 expression. | Cell Cycle | 2022 | 36346713 | PubTator, text mining | PubMed |
| Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma. | BMC Gastroenterol | 2022 | 36344926 | PubTator, text mining | PubMed |
| Identifying lncRNA-disease association based on GAT multiple-operator aggregation and inductive matrix completion. | Front Genet | 2022 | 36338997 | PubTator, text mining | PubMed |
| Exosome-encapsulated ncRNAs: Emerging yin and yang of tumor hallmarks. | Front Genet | 2022 | 36338993 | PubTator, text mining | PubMed |
| Non-coding RNAs as potential biomarkers in osteosarcoma. | Front Genet | 2022 | 36338952 | PubTator, text mining | PubMed |
| Alternative and aberrant splicing of human endogenous retroviruses in cancer. What about head and neck? -A mini review. | Front Oncol | 2022 | 36338752 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=31